Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The bypass angioplasty revascularization investigation (BARI)

Circulation

Volumn 96, Issue 6, 1997, Pages 1761-1769

  Frye, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Angioplasty; Bypass; Coronary disease; Diabetes mellitus; Trials

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0343036110     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.96.6.1761     Document Type: Article

References (53)

1. Abbott RD, Donahue RP, Kannel WB, Wilson PWF. The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham Study. JAMA. 1988;260:3456-3460.
2. Butler WJ, Osrander LD Jr, Carman WJ, Lamphiear DE. Mortality from coronary heart disease in the Tecumseh Study: long-term effect of diabetes mellitus, glucose intolerance, and other risk factors. Am J Epidemiol. 1985;121:541-547.
3. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population. Diabetes. 1974;23:105-111.
4. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease: chicken, egg or neither? Diabetologia. 1984; 26:99-102.
5. Malmberg K, Ryden L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J. 1988;9:259-264.
6. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12 year cardiovascular mortality from men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434-444.
7. Manske CL, Wang Y, Wilson RF, White CW. Coronary revascularization may improve short term survival in insulin-dependent diabetics considered for renal transplantation. Circulation. 1991; 84(suppl II):II-516. Abstract.
8. Chychota MN, Gan GT, Pluth JR, Wallace RB, Danielson GK. Myocardial revascularization: comparison of operability and surgical results in diabetic and nondiabetic patients. J Thorac Cardiovasc Surg. 1973;65:856-862.
9. Engelman RM, Bhat JG, Glassman E, Spencer FC, Boyd AD, Pasternak BS, Reed GE, Isom OW. The influence of diabetes and hypertension on the results of coronary revascularization. Am J Cardiol. 1975;35:135. Abstract.
10. McLaughlin P, Morton B, McLaughlin M, Trimble A, March J. Long-term effect of hyperlipidemia, diabetes and smoking on graft patency and progression of disease following aorto-coronary bypass. Circulation. 1974;49(suppl III):III-191. Abstract.
11. Verska JJ, Walker WJ. Aortocoronary bypass in the diabetic patient. Am J Cardiol. 1975;35:774-777.
12. Kip K, Faxon D, Detre K, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients (PTCA): the NHLBI PTCA Registry. Circulation. 1996;94:1818-1825.
13. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS, Morris DC, King SB. Influence of diabetes on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979-989.
14. Califf RM, Fortin DF, Frid DJ, Harlan WR III, Ohman EM, Bengtson JR, Nelson CL, Tcheng JE, Mark DB, Stack RS. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol. 1991;17:2B-13B.
15. Carrozza JP, Kuntz KE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993;118:344-349.
16. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation. 1991:84(suppl V):V-1-V-27.
17. Bourassa MG, Roubin GS, Detre KM, Sopko G, Krone RJ, Attabuto MJ, Bjerregaad P, Bolling S, Herman MV, Frye R, and the BARI Study Group. Bypass Angioplasty Revascularization Investigation (BARI): patient screening, selection and recruitment. Am J Cardiol. 1995;75:3C-8C.
18. Rogers WJ, Alderman RL, Chaitman BR, DiSciascio G, Horan M, Lytle B, Mock MB, Rosen AD, Sutton-Tyrrell K, Weiner BH, Whitlow PL, and the BARI Study Group. Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data. Am J Cardiol. 1995;75:9C-17C.
19. Schaff HV, Rosen AD, Shemin RJ, Leclerc Y, Wareing TH, Aguirre FV, Sopko G, Vander Salm TJ, Loop FD, and the BARI Investigators. Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1995; 75:18C-26C.
20. Williams DO, Baim DS, Bates E, Bonan R, Bost JE, Cowley M, Faxon DP, Feit F, Jones R, Kellett MA, Kelsey SF, Sopko G, Stadius M, Topol EJ, and the BARI Investigators. Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1995;75:27C-33C.
21. The BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217-225.
22. Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud GL, for the TIMI Investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, phase II. Circulation. 1992;85: 1254-1264.
23. Chaitman BR, Zhou SH, Tamesis B, Rosen A, Terry AB, Zumbehl KM, Stoke K, Takase B, Gussak I, Rautaharju PM. Methodology of serial ECG classification using an adaptation of the NOVACODE for Q-wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI). J Electrocardiol. 1996;29: 265-277.
24. Prinease RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Boston, Mass: John Wright PGS Inc; 1982.
25. Alderman EL, Stadius M. The angiographic definitions of the Bypass Angioplasty Revascularization Investigations. Coron Artery Dis. 1992;3:1189-1297.
26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
27. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-220.
28. CABRI: Long-term follow-up of European Revascularization Trials. Presented at the 68th Scientific Sessions, Plenary Session XII, of the American Heart Association, Anaheim, Calif, November 16, 1995.
29. King SB, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao XG, for the Emory Angioplasty Versus Surgery Trial (EAST). A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med. 1994;331:1044-1050.
30. Peduzzi P, Detre K, Murphy ML, Thomsen J, Hultgren H, Takaro T, and the Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Ten-year incidence of myocardial infarction and prognosis after infarction. Circulation. 1991; 83:747-755.
31. Alderman EL. Late benefit of coronary surgery on mortality from myocardial infarction. Circulation. 1991;83:1087-1089.
32. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and progress. J Am Coll Cardiol. 1992;20:736-744.
33. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM. Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol. 1988;62:665-669.
34. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T, Braunwald E, Jaffe AS, and the MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol. 1989;14:49-57.
35. Shindler DM, Kostis JB, Yusef S, Quinones MA, Pitt B, Stewart D, Pinkett T, Ghali JK, Wilson AC, for the SOLVD Investigators. Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registry. Am J Cardiol. 1996;77:1017-1020.
36. Smith JW, Marcus FI, Serokman R. Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol. 1984;54:718-721.
37. Shehadeh A, Regan TJ. Cardiac consequences of diabetes mellitus. Clin Cardiol. 1995;18:301-305.
38. Nesto RW, Phillips RT, Kett KG, Hill T, Perper E, Young E, Leland OS. Angina and exertional myocardial ischemia in diabetic and non-diabetic patients: assessment by thallium scintigraphy. Ann Intern Med. 1988;108:170-175.
39. Margolis JR, Kannel SW, Feinlieb M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction, silent and symptomatic: 18 year follow-up: the Framingham Study. Am J Cardiol. 1973;32:1-7.
40. Zarich S, Waxman S, Freeman RT, Mittleman M, Hegarty P, Nesto RW. Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol. 1994;24:956-962.
41. + channel blocker. Circulation. 1994;90:700-705.
42. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation 1995;92: 3337-3349.
43. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
44. Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation. 1995;91:635-640.
45. Sobel BE. Altered fibrinolysis and platelet function in the development of vascular complications of diabetes. Curr Opin Endocrinol Diabetes. 1996;3:355-360.
46. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
47. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996;124:127-130.
48. Malmberg K, Ryden L. Intense metabolic control decreases long-term mortality and morbidity in diabetes with myocardial infarction. J Am Coll Cardiol. 1996;27(2 suppl A):82A. Abstract.
49. Yudkin JS. How can we best prolong life? Benefits of coronary risk factor reduction in nondiabetic and diabetic subjects. Br Med J. 1993;306:1313-1318.
50. Detre K, Rosen A, Jones R, Rogers W, Mock M, Faxon D, Bourassa M, Feit F, Cowley M, Loop F, and the BARI Investigators. Is five-year mortality different for treatment by choice vs. random assignment in the Bypass Angioplasty Revascularization Investigation (BARI). J Coll Cardiol. 1996;29(suppl):243A. Abstract.
51. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M-A, for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
52. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331: 496-501.
53. Warth DC, Leon MB, O'Neill W, Zacca N, Polissar NL, Buchbinder M. Rotational Atherectomy Multicenter Registry: acute results, complications and 6-month follow-up in 709 patients. JAm Coll Cardiol. 1994;24:641-648.